Clinical trial

Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer

NCT07484776

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2026-02-10

PhaseNA

Study timeline

Study start (actual)2026-02-10Date precision: day

Registry last updated2026-03-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Triple-Negative Breast Cancer (TNBC)unresolved

Interventions

Cardiovascular training at maximal fat oxidation (FATmax)OTHER

Cardiovascular training at maximal aerobic power (MAP)OTHER

Resistance trainingOTHER

Sponsors & collaborators

Universidad Europea de Madridlead sponsor

European University of Madridcollaborator

Hospital Universitario Severo Ochoacollaborator

Hospital Universitario Infanta Leonorcollaborator

Fundación de Investigación Biomédica - Hospital Universitario de La Princesacollaborator

Mapped research locations

MadridMadrid, Spain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07484776 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.